Skip to content
2000
Volume 32, Issue 1
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Introduction

Endometriosis, a prevalent women's health condition, is associated with persistent pelvic pain and infertility. Despite ongoing research, its precise disease mechanism remains elusive, impeding the discovery of a definitive cure. However, the progression of this disease is driven by three central factors, namely estrogen, progesterone, and inflammatory processes. The current work summarizes an evaluation of hormonal drug therapy in endometriosis, highlighting pathogenesis, clinical studies, and the anticipated role of AI in improving diagnostic accuracy and therapeutic results.

Methods

Current information related to endometriosis and the application of AI in its diagnosis and treatment were evaluated through an in-depth literature search in the PubMed database and Google Scholar search engine.

Results

The current treatment modalities for this disease encompass drug therapy and surgery. In line with key contributing factors, the first-line pharmaceutical treatment revolves around progestin therapy, which involves administration either alone or in combination with a small amount of estrogen. Each medication is linked to certain drawbacks, encompassing bone loss associated with progesterone-only therapy, considerable cost implications, and heightened risks of bleeding, spotting, and drug intolerance when utilizing combined progesterone-estrogen therapy.

Conclusion

Many clinical studies on endometriosis are currently investigating the overall impact of the therapeutic approach involving progesterone-estrogen therapy with respect to the treatment of pelvic pain, health-related quality of life, cost-effectiveness, and tolerability. The rise of artificial intelligence and its advanced data processing capabilities present a promising opportunity to revolutionize endometriosis diagnosis and treatment by offering novel approaches.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128354055250312014359
2025-04-08
2025-12-08

  • From This Site

    /content/journals/cpd/10.2174/0113816128354055250312014359
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. TangW. ZhuX. BianL. ZhangB. Research progress of dydrogesterone in the treatment of endometriosis.Eur. J. Obstet. Gynecol. Reprod. Biol.202429612012510.1016/j.ejogrb.2024.02.03438430648
     [Google Scholar]
  2. ShiJ. TanX. FengG. ZhuoY. JiangZ. BandaS. WangL. ZhengW. ChenL. YuD. GuoC. Research advances in drug therapy of endometriosis.Front. Pharmacol.202314119901010.3389/fphar.2023.119901037416064
     [Google Scholar]
  3. KoninckxP.R. FernandesR. UssiaA. SchindlerL. WattiezA. Al-SuwaidiS. AmroB. Al-MaamariB. HakimZ. TahlakM. Pathogenesis based diagnosis and treatment of endometriosis.Front. Endocrinol.20211274554810.3389/fendo.2021.74554834899597
     [Google Scholar]
  4. Topçu EG, Akgün N, Karacan T, et al. Medical treatment in endometriosis.Available from: https://www.endometriozisdernegi.org/wp-content/uploads/2021/03/endotaniing.docx-7- mart-2021.pdf
     [Google Scholar]
  5. BedaiwyM.A. AlfarajS. YongP. CasperR. New developments in the medical treatment of endometriosis.Fertil. Steril.2017107355556510.1016/j.fertnstert.2016.12.02528139238
     [Google Scholar]
  6. GiudiceL.C. KaoL.C. Endometriosis.Lancet200436494471789179910.1016/S0140‑6736(04)17403‑515541453
     [Google Scholar]
  7. MeulemanC. VandenabeeleB. FieuwsS. SpiessensC. TimmermanD. D’HoogheT. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners.Fertil. Steril.2009921687410.1016/j.fertnstert.2008.04.05618684448
     [Google Scholar]
  8. GuoS.W. WangY. The prevalence of endometriosis in women with chronic pelvic pain.Gynecol. Obstet. Invest.200662312113010.1159/00009301916675908
     [Google Scholar]
  9. MaddernJ. GrundyL. CastroJ. BrierleyS.M. Pain in endometriosis.Front. Cell. Neurosci.20201459082310.3389/fncel.2020.59082333132854
     [Google Scholar]
  10. SurreyE. SolimanA.M. TrenzH. Blauer-PetersonC. SluisA. Impact of endometriosis diagnostic delays on healthcare resource utilization and costs.Adv. Ther.20203731087109910.1007/s12325‑019‑01215‑x31960340
     [Google Scholar]
  11. DungateB. TuckerD.R. GoodwinE. YongP.J. Assessing the utility of artificial intelligence in endometriosis: Promises and pitfalls.Womens Health2024201745505724124812110.1177/1745505724124812138686828
     [Google Scholar]
  12. AllaireC. BedaiwyM.A. YongP.J. Diagnosis and management of endometriosis.CMAJ202319510E363E37110.1503/cmaj.22063736918177
     [Google Scholar]
  13. KleczykEJ PeriA YadavT KomeraR PeriM GuduruV Predicting endometriosis onset using machine learning algorithms. 202010.21203/rs.3.rs‑135736/v1
     [Google Scholar]
  14. HickeyM. BallardK. FarquharC. Endometriosis.BMJ2014348g175210.1136/bmj.g175224647161
     [Google Scholar]
  15. BullettiC. CocciaM.E. BattistoniS. BoriniA. Endometriosis and infertility.J. Assist. Reprod. Genet.201027844144710.1007/s10815‑010‑9436‑120574791
     [Google Scholar]
  16. CollinsJ.A. BurrowsE.A. WillanA.R. The prognosis for live birth among untreated infertile couples.Fertil. Steril.1995641222810.1016/S0015‑0282(16)57650‑X7789569
     [Google Scholar]
  17. LalaniS. ChoudhryA.J. FirthB. BacalV. WalkerM. WenS.W. SinghS. AmathA. HodgeM. ChenI. Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis.Hum. Reprod.201833101854186510.1093/humrep/dey26930239732
     [Google Scholar]
  18. MaggioreULR FerreroS. MangiliG. BergaminiA. InversettiA. GiorgioneV. ViganòP. CandianiM. A systematic review on endometriosis during pregnancy: Diagnosis, misdiagnosis, complications and outcomes.Hum. Reprod. Update20162217010310.1093/humupd/dmv04526450609
     [Google Scholar]
  19. BreintoftK. PinnerupR. HenriksenT.B. RytterD. UldbjergN. FormanA. ArendtL.H. Endometriosis and risk of adverse pregnancy outcome: A systematic review and meta-analysis.J. Clin. Med.202110466710.3390/jcm1004066733572322
     [Google Scholar]
  20. FarlandL.V. PrescottJ. SasamotoN. TobiasD.K. GaskinsA.J. StuartJ.J. CarusiD.A. ChavarroJ.E. HorneA.W. Rich-EdwardsJ.W. MissmerS.A. Endometriosis and risk of adverse pregnancy outcomes.Obstet. Gynecol.2019134352753610.1097/AOG.000000000000341031403584
     [Google Scholar]
  21. BullettiF.M. BerrettiniM. SciorioR. BullettiC. Artificial intelligence algorithms for optimizing assisted reproductive technology programs: A systematic review.Glob. Transl. Med.202322030810.36922/gtm.0308
     [Google Scholar]
  22. KalaitzopoulosD.R. SamartzisN. KolovosG.N. MaretiE. SamartzisE.P. EberhardM. DinasK. DaniilidisA. Treatment of endometriosis: A review with comparison of 8 guidelines.BMC Womens Health202121139710.1186/s12905‑021‑01545‑534844587
     [Google Scholar]
  23. ValleR.F. SciarraJ.J. Endometriosis: Treatment strategies.Ann. N. Y. Acad. Sci.2003997122923910.1196/annals.1290.02614644830
     [Google Scholar]
  24. KodamanP.H. Current strategies for endometriosis management.Obstet. Gynecol. Clin.20154218710125681842
     [Google Scholar]
  25. BarbaraG. BuggioL. FacchinF. VercelliniP. Medical treatment for endometriosis: Tolerability, quality of life and adherence.Front. Glob. Womens Health2021272960110.3389/fgwh.2021.72960134816243
     [Google Scholar]
  26. VannucciniS. ClemenzaS. RossiM. PetragliaF. Hormonal treatments for endometriosis: The endocrine background.Rev. Endocr. Metab. Disord.202223333335510.1007/s11154‑021‑09666‑w34405378
     [Google Scholar]
  27. RojekK. JudaA. KamińskaM. StrzodaA. StrzodaA. SowińskiW. Progestins and combined oral contraceptives in the hormonal treatment of endometriosis – A review.Eur J Clin Exp Med202321239740410.15584/ejcem.2023.2.21
     [Google Scholar]
  28. LamcevaJ. UljanovsR. StrumfaI. The main theories on the pathogenesis of endometriosis.Int. J. Mol. Sci.2023245425410.3390/ijms2405425436901685
     [Google Scholar]
  29. LiuZ. YanY. LiuZ. WangY. Inflammation and endometriosis.Front. Biosci.201621594194810.2741/443127100482
     [Google Scholar]
  30. ZhangM. XuT. TongD. LiS. YuX. LiuB. JiangL. LiuK. Research advances in endometriosis-related signaling pathways: A review.Biomed. Pharmacother.202316411490910.1016/j.biopha.2023.11490937210898
     [Google Scholar]
  31. GiudiceL.C. OskotskyT.T. FalakoS. Opoku-AnaneJ. SirotaM. Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations.FASEB J.2023379e2313010.1096/fj.20230090737641572
     [Google Scholar]
  32. DonnezJ. DolmansM.M. Endometriosis and medical therapy: From progestogens to progesterone resistance to GnRH antagonists: A review.J. Clin. Med.2021105108510.3390/jcm1005108533807739
     [Google Scholar]
  33. YilmazB.D. BulunS.E. Endometriosis and nuclear receptors.Hum. Reprod. Update201925447348510.1093/humupd/dmz00530809650
     [Google Scholar]
  34. KapoorR. StratopoulouC.A. DolmansM.M. Pathogenesis of endometriosis: New insights into prospective therapies.Int. J. Mol. Sci.202122211170010.3390/ijms22211170034769130
     [Google Scholar]
  35. MarquardtR.M. KimT.H. ShinJ.H. JeongJ.W. Progesterone and estrogen signaling in the endometrium: What goes wrong in endometriosis?Int. J. Mol. Sci.20192015382210.3390/ijms2015382231387263
     [Google Scholar]
  36. KoukouraO. SifakisS. SpandidosD.A. DNA methylation in endometriosis (Review).Mol. Med. Rep.20161342939294810.3892/mmr.2016.492526934855
     [Google Scholar]
  37. KimJ.J. KuritaT. BulunS.E. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Endocr. Rev.201334113016210.1210/er.2012‑104323303565
     [Google Scholar]
  38. RižnerT.L. Estrogen metabolism and action in endometriosis.Mol. Cell. Endocrinol.20093071-281810.1016/j.mce.2009.03.02219524121
     [Google Scholar]
  39. BeckerC.M. BokorA. HeikinheimoO. HorneA. JansenF. KieselL. KingK. KvaskoffM. NapA. PetersenK. SaridoganE. TomassettiC. van HanegemN. VulliemozN. VermeulenN. AltmäeS. AtaB. BallE. BarraF. BastuE. Bianco-AnilA. KnudsenU.B. BrubelR. CambitziJ. CantineauA. CheongY. DaniilidisA. De BieB. ExacoustosC. FerreroS. GelbayaT. Goetz-CollinetJ. HudelistG. HussainM. Indrielle-KellyT. KhazaliS. KumarS.L. Leone Roberti MaggioreU. MaasJ.W.M. McLaughlinH. MetelloJ. MijatovicV. MiremadiY. MuteshiC. NisolleM. OralE. PadosG. ParadesD. PluchinoN. SupramaniamP.R. SchickM. SeeberB. SeracchioliR. LaganàA.S. StavroulisA. TebacheL. UncuG. Van den BroeckU. van PeperstratenA. VereczkeyA. WolthuisA. BahatP.Y. YazbeckC. ESHRE Endometriosis Guideline Group ESHRE guideline: Endometriosis.Hum. Reprod. Open202220222hoac00910.1093/hropen/hoac00935350465
     [Google Scholar]
  40. LeeJ. ParkH.J. YiK.W. Dienogest in endometriosis treatment: A narrative literature review.Clin. Exp. Reprod. Med.202350422322910.5653/cerm.2023.0612837995750
     [Google Scholar]
  41. ElbasuenyB. GeertsM. YangE.C. AllaireC. YongP.J. BedaiwyM.A. Medical treatments of endometriosis: A review.Reprod. Dev. Med.20237316617910.1097/RD9.0000000000000053
     [Google Scholar]
  42. VercelliniP. OttoliniF. FrattaruoloM.P. BuggioL. RobertoA. SomiglianaE. Shifting from oral contraceptives to norethisterone acetate, or vice versa, because of drug intolerance: Does the change benefit women with endometriosis?Gynecol. Obstet. Invest.201883327528410.1159/00048633529486468
     [Google Scholar]
  43. Obstetricians ACo Practice bulletin no. 114: Management of endometriosis.Obstet. Gynecol.2010116122323610.1097/AOG.0b013e3181e8b07320567196
     [Google Scholar]
  44. LeylandN. CasperR. LabergeP. SinghS.S. AllenL. ArendasK. SOGC Endometriosis: Diagnosis and management.J. Endometr.2010327Suppl. 2S13221545757
     [Google Scholar]
  45. DunselmanG.A.J. VermeulenN. BeckerC. Calhaz-JorgeC. D’HoogheT. De BieB. HeikinheimoO. HorneA.W. KieselL. NapA. PrenticeA. SaridoganE. SorianoD. NelenW. European Society of Human Reproduction and Embryology ESHRE guideline: Management of women with endometriosis.Hum. Reprod.201429340041210.1093/humrep/det45724435778
     [Google Scholar]
  46. Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: A committee opinion.Fertil. Steril.2014101492793510.1016/j.fertnstert.2014.02.01224630080
     [Google Scholar]
  47. García-SáenzM. Ibarra-SalceR. Pozos-VarelaF.J. Mena-UretaT.S. Flores-VillagómezS. Santana-MataM. De Los Santos-AguilarR.G. Uribe-CortésD. Ferreira-HermosilloA. Understanding progestins: From basics to clinical applicability.J. Clin. Med.20231210338810.3390/jcm1210338837240495
     [Google Scholar]
  48. FedotchevaT. Clinical use of progestins and their mechanisms of action: Present and future.Modern Technol. Med.20211319310610.17691/stm2021.13.1.11
     [Google Scholar]
  49. McCormackP.L. Dienogest.Drugs201070162073208810.2165/11206320‑000000000‑0000020964453
     [Google Scholar]
  50. KimY.S. KimY.J. KimM.J. LeeS.J. KwonH. LeeJ.H. Novel medicine for endometriosis and its therapeutic effect in a mouse model.Biomedicines202081261910.3390/biomedicines812061933339236
     [Google Scholar]
  51. TarjanneS. NgC.H.M. ManconiF. ArolaJ. MentulaM. ManeckB. FraserI.S. HeikinheimoO. Use of hormonal therapy is associated with reduced nerve fiber density in deep infiltrating, rectovaginal endometriosis.Acta Obstet. Gynecol. Scand.201594769370010.1111/aogs.1265225865020
     [Google Scholar]
  52. ShahM. DaveB. BhagatS. RaoH. KhadelaA. ParikhN. A comprehensive review comparing conventional versus traditional remedies in the treatment of endometriosis with futuristic insights.Future J. Pharm. Sci.20241013510.1186/s43094‑024‑00609‑1
     [Google Scholar]
  53. MikušM. GoldštajnMS LaganàA.S. VukorepaF. ĆorićM. Clinical efficacy, pharmacokinetics, and safety of the available medical options in the treatment of endometriosis-related pelvic pain: A scoping review.Pharmaceuticals (Basel)2023169131510.3390/ph1609131537765123
     [Google Scholar]
  54. TokushigeN. MarkhamR. RussellP. FraserI.S. Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis.Fertil. Steril.20099241234123910.1016/j.fertnstert.2008.07.177418976764
     [Google Scholar]
  55. YamamotoN. Wada-HiraikeO. HiranoM. HirataT. HaradaM. HirotaY. KogaK. FujiiT. OsugaY. Ovarian reserve may influence the outcome of bone mineral density in patients with long-term use of dienogest.SAGE Open Med.202192050312121100599210.1177/2050312121100599235154758
     [Google Scholar]
  56. GalloMF NandaK GrimesDA LopezLM SchulzKF 20 µg versus > 20 µg estrogen combined oral contraceptives for contraception.Cochrane Database Syst. Rev.20138CD00398910.3390/ph1609131537765123
     [Google Scholar]
  57. VercelliniP BuggioL BerlandaN BarbaraG SomiglianaE BosariS Estrogen-progestins and progestins for the management of endometriosis.Fertil Steril201610671552157110.1016/j.fertnstert.2016.10.022
     [Google Scholar]
  58. ReisF.M. PetragliaF. TaylorR.N. Endometriosis: Hormone regulation and clinical consequences of chemotaxis and apoptosis.Hum. Reprod. Update201319440641810.1093/humupd/dmt01023539633
     [Google Scholar]
  59. MeresmanG.F. AugéL. BarañaoR.I. LombardiE. TesoneM. SueldoC. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis.Fertil. Steril.20027761141114710.1016/S0015‑0282(02)03099‑612057719
     [Google Scholar]
  60. ChenL.H. LoW.C. HuangH.Y. WuH.M. A lifelong impact on endometriosis: Pathophysiology and pharmacological treatment.Int. J. Mol. Sci.2023248750310.3390/ijms2408750337108664
     [Google Scholar]
  61. AkahaneT. SekizawaA. PurwosunuY. NagatsukaM. OkaiT. The role of p53 mutation in the carcinomas arising from endometriosis.Int. J. Gynecol. Pathol.200726334535110.1097/pgp.0b013e31802b41a817581423
     [Google Scholar]
  62. CarusoS. CianciA. IraciM. FavaV. Di PasquaS. CianciS. Does nomegestrol acetate plus 17β-estradiol oral contraceptive improve endometriosis-associated chronic pelvic pain in women?J. Womens Health20202991184119110.1089/jwh.2020.829132678691
     [Google Scholar]
  63. CarusoS. CianciA. SareriMI PanellaM. CarusoG. CianciS. Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis-associated chronic pelvic pain.BMC Womens Health202222114610.1186/s12905‑022‑01737‑735538479
     [Google Scholar]
  64. SurreyE.S. GnRH agonists in the treatment of symptomatic endometriosis: A review.F S Rep.202342Suppl.404510.1016/j.xfre.2022.11.00937223763
     [Google Scholar]
  65. de ZieglerD BorgheseB ChapronC Gonadotropin-releasing hormone agonists for endometriosis.N. Engl. J. Med.2008359262844
     [Google Scholar]
  66. DonnezJ. ChantraineF. NisolleM. The efficacy of medical and surgical treatment of endometriosis-associated infertility: Arguments in favour of a medico-surgical aproach.Hum. Reprod. Update200281899410.1093/humupd/8.1.8911866245
     [Google Scholar]
  67. DonnezJ. NisolleM. ClerckxF. Casanas-RouxF. SaussoyP. GillerotS. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment.BJOG1994101s102910.1111/j.1471‑0528.1994.tb13677.x8199099
     [Google Scholar]
  68. DonnezJ. TaylorH.S. TaylorR.N. AkinM.D. TatarchukT.F. WilkK. GottelandJ.P. LecomteV. BestelE. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: A randomized clinical trial.Fertil. Steril.20201141445510.1016/j.fertnstert.2020.02.11432505383
     [Google Scholar]
  69. CooperKG BhattacharyaS DanielsJP HorneAW ClarkTJ SaridoganE Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: The PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial.BMJ2024385e07900610.1136/bmj‑2023‑079006
     [Google Scholar]
  70. SteinerJ. WalterM. GosT. GuilleminG.J. BernsteinH.G. SarnyaiZ. MawrinC. BrischR. BielauH. zu SchwabedissenL. BogertsB. MyintA.M. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?J. Neuroinflammation2011819410.1186/1742‑2094‑8‑9421831269
     [Google Scholar]
  71. CandayM. SalmanS. Impact of dienogest alone or in combination with ethinylestradiol on the quality of life of women with endometriosis: A prospective cohort study.Gynecol. Obstet. Reprod. Med.2023293196205
     [Google Scholar]
  72. YurtkalA. OnculM. Comparison of dienogest or combinations with ethinylestradiol/estradiol valerate on the pain score of women with endometriosis: A prospective cohort study.Medicine202410327e3858510.1097/MD.000000000003858538968535
     [Google Scholar]
  73. ZhangZ. WangX. WangL. LiZ. Cost-effectiveness analysis of dienogest compared with combined oral contraceptives after surgery for endometriosis.J. Minim. Invasive Gynecol.202330431231810.1016/j.jmig.2022.12.01736596391
     [Google Scholar]
  74. da Costa PinheiroD.J.P. PereiraA.M.G. AntoniniM. SalgadoIMA DiasA.T. LopesR.G.C. Tolerability of endometriosis medical treatment: A comparison between combined hormonal contraceptives and progestins.BMC Womens Health202323151010.1186/s12905‑023‑02647‑y37741998
     [Google Scholar]
  75. ShimJ.Y. GarboG. GrimstadF.W. ScatoniA. BarreraE.P. BoskeyE.R. Use of the drospirenone-only contraceptive pill in adolescents with endometriosis.J. Pediatr. Adolesc. Gynecol.202437440240610.1016/j.jpag.2024.02.00338395193
     [Google Scholar]
  76. DababouS. GarzonS. LaganàA.S. FerreroS. EvangelistiG. NoventaM. D’AlterioM.N. PalombaS. UccellaS. FranchiM. BarraF. Linzagolix: A new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas.Expert Opin. Investig. Drugs202130990391110.1080/13543784.2021.195783034278887
     [Google Scholar]
  77. FilipL. DuicăF. PrădatuA. CrețoiuD. SuciuN. CrețoiuS.M. PredescuD.V. VarlasV.N. VoineaS.C. Endometriosis associated infertility: A critical review and analysis on etiopathogenesis and therapeutic approaches.Medicina202056946010.3390/medicina5609046032916976
     [Google Scholar]
  78. MacerM.L. TaylorH.S. Endometriosis and infertility: A review of the pathogenesis and treatment of endometriosis-associated infertility.Obstet Gynecol Clin201239453554923182559
     [Google Scholar]
  79. GuoY. LuN. ZhangY. SuY. WangY. ZhangY. SunY. Comparative study on the pregnancy outcomes of in vitro fertilization–embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.Contemp. Clin. Trials20123361206121010.1016/j.cct.2012.07.00922820320
     [Google Scholar]
  80. CaoX. ChangH. XuJ. ZhengY. XiangY. XiaoB. GengX. NiL. ChuX. TaoS. HeY. MaoG. The effectiveness of different down-regulating protocols on in vitro fertilization-embryo transfer in endometriosis: A meta-analysis.Reprod. Biol. Endocrinol.20201811610.1186/s12958‑020‑00571‑632113479
     [Google Scholar]
  81. PašalićE. TambuwalaM.M. Hromić-JahjefendićA. Endometriosis: Classification, pathophysiology, and treatment options.Pathol. Res. Pract.202325115484710.1016/j.prp.2023.15484737844487
     [Google Scholar]
  82. HodgsonRM LeeHL WangR MolBW JohnsonN Interventions for endometriosis-related infertility: A systematic review and network meta-analysis.Fertil Steril2020113237438210.1016/j.fertnstert.2019.09.031
     [Google Scholar]
  83. AlkatoutI. MettlerL. BetetaC. HedderichJ. JonatW. SchollmeyerT. SalmassiA. Combined surgical and hormone therapy for endometriosis is the most effective treatment: Prospective, randomized, controlled trial.J. Minim. Invasive Gynecol.201320447348110.1016/j.jmig.2013.01.01923567095
     [Google Scholar]
  84. Stochino-LoiE. MillochauJ.C. AngioniS. TouleimatS. AboC. Chanavaz-LacherayI. HennetierC. RomanH. Relationship between patient age and disease features in a prospective cohort of 1560 women affected by endometriosis.J. Minim. Invasive Gynecol.20202751158116610.1016/j.jmig.2019.09.00431518709
     [Google Scholar]
  85. CapezzuoliT. VannucciniS. MautoneD. SorbiF. ChenH. ReisF.M. CeccaroniM. PetragliaF. Long-term hormonal treatment reduces repetitive surgery for endometriosis recurrence.Reprod. Biomed. Online202142245145610.1016/j.rbmo.2020.09.01833277193
     [Google Scholar]
  86. LeeD. KimS.K. LeeJ.R. JeeB.C. Management of endometriosis-related infertility: Considerations and treatment options.Clin. Exp. Reprod. Med.202047111110.5653/cerm.2019.0297132088944
     [Google Scholar]
  87. TanboT. FedorcsakP. Endometriosis-associated infertility: Aspects of pathophysiological mechanisms and treatment options.Acta Obstet. Gynecol. Scand.201796665966710.1111/aogs.1308227998009
     [Google Scholar]
  88. CeteraG.E. TozziA.E. ChiappaV. CastiglioniI. MerliC.E.M. VercelliniP. Artificial intelligence in the management of women with endometriosis and adenomyosis: Can machines ever be worse than humans?J. Clin. Med.20241310295010.3390/jcm1310295038792490
     [Google Scholar]
  89. DeoR.C. Machine learning in medicine.Circulation2015132201920193010.1161/CIRCULATIONAHA.115.00159326572668
     [Google Scholar]
  90. WangR. PanW. JinL. LiY. GengY. GaoC. ChenG. WangH. MaD. LiaoS. Artificial intelligence in reproductive medicine.Reproduction20191584R139R15410.1530/REP‑18‑052330970326
     [Google Scholar]
  91. Visalaxi S, Punnoose D, Muthu TS. An analogy of endometriosis recognition using machine learning techniques. In: 2021 Third International Conference on Intelligent Communication Technologies and Virtual Mobile Networks (ICICV). Tirunelveli, India, 2021, pp. 739-746.10.1109/ICICV50876.2021.9388403
  92. SerratJC Evaluation of the combination of magnetic resonance imaging and artificial intelligence in the diagnosis of endometriosis: A cross-sectional study.2022Available from: https://dugi- doc.udg.edu/handle/10256/21546
  93. MaicasG. LeonardiM. AveryJ. PanuccioC. CarneiroG. HullM.L. CondousG. Deep learning to diagnose pouch of Douglas obliteration with ultrasound sliding sign.Reprod. Fertil.20212423624310.1530/RAF‑21‑003135118401
     [Google Scholar]
  94. SivajohanB. ElgendiM. MenonC. AllaireC. YongP. BedaiwyM.A. Clinical use of artificial intelligence in endometriosis: A scoping review.NPJ Digit. Med.20225110910.1038/s41746‑022‑00638‑135927426
     [Google Scholar]
  95. GoldsteinA. CohenS. Self-report symptom-based endometriosis prediction using machine learning.Sci. Rep.2023131549910.1038/s41598‑023‑32761‑837016132
     [Google Scholar]
  96. GhaziN. ArjmandM. AkbariZ. MellatiAO Saheb-KashafH. ZamaniZ. 1H NMR- based metabolomics approaches as non-invasive tools for diagnosis of endometriosis.Int. J. Reprod. Biomed.20161411810.29252/ijrm.14.1.127141542
     [Google Scholar]
  97. HosnaA. MerryE. GyalmoJ. AlomZ. AungZ. AzimM.A. Transfer learning: A friendly introduction.J. Big Data20229110210.1186/s40537‑022‑00652‑w36313477
     [Google Scholar]
  98. VesaleE. RomanH. AboC. BenoitL. TuechJ.J. DaraiE. BendifallahS. Predictive approach in managing voiding dysfunction after surgery for deep endometriosis: A personalized nomogram.Int. Urogynecol. J. Pelvic Floor Dysfunct.20213251205121210.1007/s00192‑020‑04428‑932653970
     [Google Scholar]
  99. DuttaM. JoshiM. SrivastavaS. LodhI. ChakravartyB. ChaudhuryK. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis.Mol. Biosyst.20128123281328710.1039/c2mb25353d23079773
     [Google Scholar]
  100. BendifallahS. SuisseS. PucharA. DelbosL. PoilblancM. DescampsP. GolfierF. JorneaL. BouteillerD. TouboulC. DabiY. DaraïE. Salivary microRNA signature for diagnosis of endometriosis.J. Clin. Med.202211361210.3390/jcm1103061235160066
     [Google Scholar]
  101. AveryJ.C. DeslandesA. FregerS.M. LeonardiM. LoG. CarneiroG. CondousG. HullM.L. HullL. CarneiroG. AveryJ. O’HaraR. CondousG. KnoxS. LeonardiM. PanuccioC. SiropA. AbbottJ. Gonzalez-ChicaD. WangH. LoG. ChenT. DeslandesA. ToM-S. ZhangY. YangN. UzunerC. Holdsworth-CarsonS. NguyenT. FregerS. AbeygunasekaraN. RichardsM. SimpsonA. VoyvodicF. JenkinsM. Imagendo Study Group Noninvasive diagnostic imaging for endometriosis part 1: A systematic review of recent developments in ultrasound, combination imaging, and artificial intelligence.Fertil. Steril.2024121216418810.1016/j.fertnstert.2023.12.00838101562
     [Google Scholar]
  102. ScutariM. DenisJ-B. Bayesian networks: With examples in R, 3rd ed; Chapman and Hall/CRC 2021; pp. 274.10.1201/9780429347436
  103. PearlJ. Probabilistic reasoning in intelligent systems: Networks of plausible inference. Morgan Kaufmann Publishers Inc., San Francisco, CA, USA 1988. Available from: https://dl.acm.org/doi/book/10.5555/534975.
  104. KiserA.C. SchliepK.C. HernandezE.J. PetersonC.M. YandellM. EilbeckK. An artificial intelligence approach for investigating multifactorial pain-related features of endometriosis.PLoS One2024192e029799810.1371/journal.pone.029799838381710
     [Google Scholar]
  105. JiangN. XieH. LinJ. WangY. YinY. Diagnosis and nursing intervention of gynecological ovarian endometriosis with magnetic resonance imaging under artificial intelligence algorithm.Comput. Intell. Neurosci.20222022111010.1155/2022/312331035726287
     [Google Scholar]
  106. AlbizuA. FangR. IndahlastariA. O’SheaA. StolteS.E. SeeK.B. BoutzoukasE.M. KraftJ.N. NissimN.R. WoodsA.J. Machine learning and individual variability in electric field characteristics predict tDCS treatment response.Brain Stimul.20201361753176410.1016/j.brs.2020.10.00133049412
     [Google Scholar]
  107. Indrielle-KellyT. FrühaufF. FantaM. BurgetovaA. LavuD. DundrP. CibulaD. FischerovaD. Diagnostic accuracy of ultrasound and MRI in the mapping of deep pelvic endometriosis using the international deep endometriosis analysis (IDEA) consensus.BioMed Res. Int.202020201358398910.1155/2020/358398932083128
     [Google Scholar]
  108. ZhangY. WangH. ButlerD. ToM-S. AveryJ. HullM.L. CarneiroG. Distilling missing modality knowledge from ultrasound for endometriosis diagnosis with magnetic resonance images.2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI)Cartagena, Colombia, 2023, pp. 1-5.10.1109/ISBI53787.2023.10230667
     [Google Scholar]
  109. AveryJ.C. KnoxS. DeslandesA. LeonardiM. LoG. WangH. ZhangY. Holdsworth-CarsonS.J. Thi NguyenT.T. CondousG.S. CarneiroG. HullM.L. HullL. CarneiroG. AveryJ. O’HaraR. CondousG. KnoxS. LeonardiM. PanuccioC. SiropA. AbbottJ. Gonzalez-ChicaD. WangH. LoG. ChenT. DeslandesA. ToM-S. ZhangY. YangN. UzunerC. Holdsworth-CarsonS. NguyenT. FregerS. AbeygunasekaraN. RichardsM. SimpsonA. VoyvodicF. JenkinsM. Imagendo Study Group Noninvasive diagnostic imaging for endometriosis part 2: A systematic review of recent developments in magnetic resonance imaging, nuclear medicine and computed tomography.Fertil. Steril.2024121218921110.1016/j.fertnstert.2023.12.01738110143
     [Google Scholar]
  110. RajputD. WangW.J. ChenC.C. Evaluation of a decided sample size in machine learning applications.BMC Bioinformatics20232414810.1186/s12859‑023‑05156‑936788550
     [Google Scholar]
  111. VabalasA. GowenE. PoliakoffE. CassonA.J. Machine learning algorithm validation with a limited sample size.PLoS One20191411e022436510.1371/journal.pone.022436531697686
     [Google Scholar]
  112. KernbachJM StaartjesVE Foundations of machine learning-based clinical prediction modeling: Part II-generalization and overfitting.Acta Neurochir. Suppl.2022134152110.1007/978‑3‑030‑85292‑4_3
     [Google Scholar]
  113. YingX. An overview of overfitting and its solutions.J. Phys.: Conf. Ser.20191168022022
     [Google Scholar]
  114. KokolP. KokolM. ZagoranskiS. Machine learning on small size samples: A synthetic knowledge synthesis.Sci. Prog.202210510036850421102977710.1177/0036850421102977735220816
     [Google Scholar]
  115. LauferM.R. GoiteinL. BushM. CramerD.W. EmansS.J. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy.J. Pediatr. Adolesc. Gynecol.199710419920210.1016/S1083‑3188(97)70085‑89391902
     [Google Scholar]
  116. ReeseK.A. ReddyS. RockJ.A. Endometriosis in an adolescent population: The Emory experience.J. Pediatr. Adolesc. Gynecol.19969312512810.1016/S1083‑3188(96)70021‑98795787
     [Google Scholar]
  117. KoninckxP.R. MeulemanC. DemeyereS. LesaffreE. CornillieF.J. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain.Fertil. Steril.199155475976510.1016/S0015‑0282(16)54244‑72010001
     [Google Scholar]
  118. LauferM.R. SanfilippoJ. RoseG. Adolescent endometriosis.J. Pediatr. Adolesc. Gynecol.2003163 Suppl.S31110.1016/S1083‑3188(03)00066‑412742180
     [Google Scholar]
  119. SarıdoğanE. Adolescent endometriosis.Eur. J. Obstet. Gynecol. Reprod. Biol.2017209464910.1016/j.ejogrb.2016.05.01927342684
     [Google Scholar]
  120. ZannoniL. FornoS.D. ParadisiR. SeracchioliR. Endometriosis in adolescence: Practical rules for an earlier diagnosis.Pediatr. Ann.2016459e332e33510.3928/19382359‑20160727‑0327622918
     [Google Scholar]
  121. MarshE.E. LauferM.R. Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly.Fertil. Steril.200583375876010.1016/j.fertnstert.2004.08.02515749511
     [Google Scholar]
  122. SaridoğanE. Endometriosis in teenagers.Womens Health201511570570910.2217/whe.15.5826315257
     [Google Scholar]
  123. ChapronC. Lafay-PilletM.C. MonceauE. BorgheseB. NgôC. SouzaC. de ZieglerD. Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis.Fertil. Steril.201195387788110.1016/j.fertnstert.2010.10.02721071024
     [Google Scholar]
  124. HanassabS. AbbaraA. YeungA.C. VoliotisM. Tsaneva-AtanasovaK. KelseyT.W. TrewG.H. NelsonS.M. HeinisT. DhilloW.S. The prospect of artificial intelligence to personalize assisted reproductive technology.NPJ Digit. Med.2024715510.1038/s41746‑024‑01006‑x38429464
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128354055250312014359
Loading
Current Insights into Endometriosis: Hormonal Management, Clinical Outcomes, and Opportunities for Progress
Curr. Pharm. Des. 32, 1 (2026); https://doi.org/10.2174/0113816128354055250312014359
/content/journals/cpd/10.2174/0113816128354055250312014359
/content/journals/cpd/10.2174/0113816128354055250312014359
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): artificial intelligence; Endometriosis; estrogen; infertility; inflammation; pelvic pain; progesterone

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test